Abstract P2-04-08: BGB324, a selective small molecule inhibitor of the receptor tyrosine kinase AXL, enhances immune checkpoint inhibitor efficacy in mammary adenocarcinoma
2016 ◽
2008 ◽
Vol 6
(12)
◽
pp. 177
2009 ◽
Vol 15
(9)
◽
pp. 3058-3067
◽
2006 ◽
Vol 71
(10)
◽
pp. 1422-1434
◽
Keyword(s):
2008 ◽
Vol 6
(12)
◽
pp. 176